Upadacitinib
| Upadacitinib | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Upadacitinib is a medication used in the treatment of several inflammatory conditions. It is classified as a Janus kinase inhibitor, which works by interfering with the signaling pathways that lead to inflammation.
Mechanism of Action[edit]
Upadacitinib functions by selectively inhibiting the activity of Janus kinase (JAK) enzymes. These enzymes are crucial in the signaling pathways of various cytokines and growth factors that are involved in hematopoiesis and immune function. By inhibiting JAKs, upadacitinib reduces the inflammatory response that is characteristic of autoimmune diseases.
Medical Uses[edit]
Upadacitinib is primarily used in the treatment of:
Rheumatoid Arthritis[edit]
In patients with moderate to severe rheumatoid arthritis, upadacitinib is used to reduce symptoms and improve physical function. It is often prescribed when patients have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).
Psoriatic Arthritis[edit]
For individuals with active psoriatic arthritis, upadacitinib helps in reducing joint pain and swelling, as well as improving skin symptoms associated with the condition.
Atopic Dermatitis[edit]
Upadacitinib is also indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents who are candidates for systemic therapy.
Ulcerative Colitis[edit]
In the context of ulcerative colitis, upadacitinib is used to induce and maintain clinical remission in patients with moderate to severe disease.
Side Effects[edit]
Common side effects of upadacitinib include:
Serious side effects may include:
- Increased risk of serious infections
- Thrombosis
- Liver enzyme elevations
Administration[edit]
Upadacitinib is administered orally, typically once daily. The dosage may vary based on the specific condition being treated and the patient's response to the medication.
Related pages[edit]
- Janus kinase inhibitor
- Rheumatoid arthritis
- Psoriatic arthritis
- Atopic dermatitis
- Ulcerative colitis
-
Upadacitinib
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
